Editors

Editors-in-Chief

Fred H. Menko, MD, PhD
Department of Clinical Genetics, Antoni van Leeuwenhoek/ Netherlands Cancer Institute, Amsterdam, The Netherlands

Hans F.A. Vasen, MD, PhD
Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands

Gabriel Capellá, MD
Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL Program, L'Hospitalet, Barcelona, Spain

Associate Editors

C. Richard Boland, MD
University of California San Diego, La Jolla, CA, USA

Judy E. Garber, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, USA

Steven Narod, MD, FRCPC, FRSC
Womens College Research Institute, Toronto, ON, Canada

Ian Tomlinson, MD, FRS
University of Oxford, Oxford, UK

Editorial Board Members

Lauri Aaltonen, MD, PhD, University of Helsinki, Helsinki, Finland
Maria Isabel Achatz, MD, PhD, Hospital Sírio-Libanês: São Paulo, Sao Paulo, Brazil
Aysel Ahadova, PhD, University Hospital Heidelberg, Heidelberg, Germany
Karin Alvarez, PhD, Clínica Universidad de Los Andes, Santiago, Chile
Margreet Ausems, MD, PhD, University of Utrecht, Utrecht, Netherlands
Francesc Balaguer, MD, PhD, Gastroenterology Department Hospital Clinic of Barcelona, Spain
Daniel Buchanan, PhD, University of Melbourne Centre for Cancer Research, Melbourne, Australia
Chrystelle Colas, MD, PhD, Institut Curie, Paris, France
Mev Dominguez-Valentin, PhD, Oslo University Hospital, Oslo, Norway
Rosalind Eeles, PhD, MA, FRCP, FRCR, Institute of Cancer Research, London, United Kingdom
D Gareth R Evans, MB, BS, MD, FRCP, FLSW, FRCOG, ad eundem, University of Manchester, Manchester, United Kingdom
Yael Goldberg, MD, Raphael Recanati Genetic Institute, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
Ladan Goshayeshi, MD, Mashad University of Medical Science, Mashad, Iran
Heather Hampel, MS, CGC, City of Hope, Duarte, CA, United States
Shirley Hodgson, DM, FRCP, St George's University of London, London, United Kingdom
Elke Holinski-Feder, MD, MGZ-Medizinisch Genetiches Zentrum, München, Germany
Andrew R. Latchford, PhD, FRCP, St Mark’s Hospital, London, United Kingdom
Finlay Macrae, AO, MBBS,MD, FRACP, FRCP, AGAF, MWGO, Royal Melbourne Hospital, Parkville, Victoria, Australia
Eamonn Maher, MD, FRCP, FMedSci, University of Cambridge, Cambridge, United Kingdom
Gabriela Moeslein, MD, Heinrich Heine University, Düsseldorf, Northrhine-Westphalia, Germany
Joanne Ngeow, MBBS, MRCP, MMed, FAMS, MPH, National Cancer Centre, Singapore, Singapore
Maartje Nielsen, MD, PhD, Leiden University Medical Center, Leiden, Netherlands
Raj Ramesar, PhD, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa
Benedito Rossi, PhD, MD, Hospital Sirio Libanes, Sao Paulo, Brasil
Laura Schmidt, PhD, National Cancer Institute/NIH, Bethesda, MD, United States
Sapna Syngal, MD, MPH, Harvard University, Boston, MA, United States
Amit Tirosh, MD, PhD, Chaim Sheba Medical Center, Tel Aviv University Faculty of Medicine, Tel Aviv, Israel
Laura Valle, PhD, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain
Allison Werner-Lin, PhD, LCSW, University of Pennsylvania, Philadelphia, PA, United States
Katharina Wimmer, PhD, Medical University Innsbruck, Innsbruck, Austria
Matthew Yurgelun, MD, FASCO, Dana-Farber Cancer Institute, Boston, MA, United States